Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Public Health and Surveillance

Date Submitted: Aug 16, 2021
Date Accepted: Sep 20, 2021
Date Submitted to PubMed: Sep 30, 2021

The final, peer-reviewed published version of this preprint can be found here:

The Impact of Public Health Events on COVID-19 Vaccine Hesitancy on Chinese Social Media: National Infoveillance Study

Zhang Z, Feng G, Xu J, Zhang Y, Li J, Huang J, Akinwunmi B, Zhang CJ, Ming WK

The Impact of Public Health Events on COVID-19 Vaccine Hesitancy on Chinese Social Media: National Infoveillance Study

JMIR Public Health Surveill 2021;7(11):e32936

DOI: 10.2196/32936

PMID: 34591782

PMCID: 8582758

Impact of Public Health Event on COVID-19 Vaccine Hesitancy on Social Media: National Infoveillance Study

  • Zizheng Zhang; 
  • Guanrui Feng; 
  • Jiahong Xu; 
  • Yimin Zhang; 
  • Jinhui Li; 
  • Jian Huang; 
  • Babatunde Akinwunmi; 
  • Casper J.P. Zhang; 
  • Wai-Kit Ming

ABSTRACT

Background:

The ongoing Coronavirus 2019 (COVID-19) pandemic has brought unprecedented challenges to every country in the world. A call for global vaccination of COVID-19 plays a pivotal role in the fight against this virus. With the development of COVID-19 vaccines, public willingness to accept a vaccination has become an important concern of public health given the vaccine hesitancy observed in the world. Social media is powerful in monitoring public attitudes and assess the dissemination, which would provide valuable information for policy makers.

Objective:

This study aimed to investigate the responses of vaccine positivity on social media when public health events were reported.

Methods:

A total of 340,783 vaccine-related posts was captured with the poster’s information on Weibo, the biggest social platform in China. After data cleaning, 156,223 posts were included in the subsequent analysis. By using pandas and SnowNLP Python libraries, posts were classified into 2 categories, positive and negative. After model training and sentiment analysis, the proportion of positive posts was computed to measure the public positivity toward the COVID-19 vaccine.

Results:

The positivity of COVID-19 vaccine in China tends to fluctuate over time in the range of 45.7% to 77.0% and is intuitively correlated with public health events. In terms of gender, males were more positive (70.0% of the time) than females. In terms of region, when regional epidemics arose, not only the region with the epidemic and surrounding regions but even the whole country showed more positive attitudes to varying degrees. When the epidemic subsided temporarily, positivity decreased with varying degrees in each region.

Conclusions:

In China, public attitudes of COVID-19 vaccination vary from gender and region. A regional epidemic or news on social media may cause variations in willingness to accept a vaccination. It is crucial for policy makers to adjust their policies through the use of positive incentives with prompt responses to pandemic-related news to promote vaccination acceptance.


 Citation

Please cite as:

Zhang Z, Feng G, Xu J, Zhang Y, Li J, Huang J, Akinwunmi B, Zhang CJ, Ming WK

The Impact of Public Health Events on COVID-19 Vaccine Hesitancy on Chinese Social Media: National Infoveillance Study

JMIR Public Health Surveill 2021;7(11):e32936

DOI: 10.2196/32936

PMID: 34591782

PMCID: 8582758

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.